These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22795710)

  • 61. Comparison of the efficacy and safety of paclitaxel-eluting coroflex please stents and paclitaxel-eluting stents in patients with coronary artery disease: a randomized PIPA trial.
    Kim HS; Park SJ; Park DW; Park SW; Cheong SS; Lee SG; Cho BR; Lee SW; Lee NH; Lee K;
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):799-806. PubMed ID: 22120995
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Effects of early submaximal cardiopulmonary exercise test and cardiac rehabilitation for patients with acute myocardial infarction after percutaneous coronary intervention: a comparative study].
    Che L; Wang LM; Jiang JF; Xu WJ; Zhang QP
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1820-3. PubMed ID: 19040016
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Early administration of abciximab in patients with acute myocardial infarction improves angiographic and clinical outcome after primary angioplasty.
    Beeres SL; Oemrawsingh PV; Warda HM; Bechan R; Atsma DE; Jukema JW; van der Wall EE; Schalij MJ
    Catheter Cardiovasc Interv; 2005 Aug; 65(4):478-83. PubMed ID: 15973655
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Everolimus-eluting stents compared with paclitaxel-eluting stents for treatment of coronary in-stent restenoses.
    Markovic S; Paliskyte R; Rottbauer W; Wöhrle J
    Cardiovasc Revasc Med; 2012; 13(6):307-10. PubMed ID: 23164475
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography.
    Cassese S; Byrne RA; Tada T; Pinieck S; Joner M; Ibrahim T; King LA; Fusaro M; Laugwitz KL; Kastrati A
    Heart; 2014 Jan; 100(2):153-9. PubMed ID: 24270744
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study.
    Mehilli J; Byrne RA; Tiroch K; Pinieck S; Schulz S; Kufner S; Massberg S; Laugwitz KL; Schömig A; Kastrati A;
    J Am Coll Cardiol; 2010 Jun; 55(24):2710-6. PubMed ID: 20226618
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).
    Waksman R; Kirtane AJ; Torguson R; Cohen DJ; Ryan T; Räber L; Applegate R; Waxman S; Gordon P; Kaneshige K; Leon MB;
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1093-102. PubMed ID: 25240540
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Angiographic late lumen loss at the site of overlap of multiple Cypher™ sirolimus-eluting stents: ALSOCE study.
    Takamiya Y; Miura S; Tsuchiya Y; Fukuda Y; Zhang B; Kuwano T; Ike A; Yanagi D; Kubota K; Mori K; Iwata A; Nishikawa H; Kawamura A; Miller N; Matsuo K; Shirai K; Saku K
    J Cardiol; 2011 Mar; 57(2):187-93. PubMed ID: 21177074
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Serum concentration of insulin-like growth factor-I, but not tumor necrosis factor-alpha, measured twelve months after stenting of the infarct-related artery, is associated with in-stent restenosis.
    Szkodzinski J; Hudzik B; Romanowski W; Wilczek K; Danikiewicz A; Gasior M; Polonski L; Zubelewicz-Szkodzinska B
    J Biol Regul Homeost Agents; 2010; 24(2):149-56. PubMed ID: 20487628
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Regular Drug-Eluting Stent vs Dedicated Coronary Bifurcation BiOSS Expert Stent: Multicenter Open-Label Randomized Controlled POLBOS I Trial.
    Gil RJ; Bil J; Džavík V; Vassilev D; Kern A; Formuszewicz R; Zalewska-Adamiec M; Dobrzycki S
    Can J Cardiol; 2015 May; 31(5):671-8. PubMed ID: 25828372
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The value of stress single-photon emission computed tomography imaging performed routinely at 6 months in asymptomatic patients for predicting angiographic restenosis after successful direct percutaneous intervention for acute ST elevation myocardial infarction.
    Isaaz K; Afif Z; Prévot N; Cerisier A; Lamaud M; Richard L; Faure E; Granjon D; Robin C; Hassan MS; Da Costa A; Dubois F
    Coron Artery Dis; 2008 Mar; 19(2):89-97. PubMed ID: 18300745
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up.
    Zhao LP; Xu WT; Wang L; Li H; Shao CL; Gu HB; Chan SP; Xu HF; Yang XJ
    Coron Artery Dis; 2015 Jan; 26(1):5-10. PubMed ID: 25211654
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Circulating endothelial progenitor cells are inversely correlated with in-stent restenosis in patients with non-ST-segment elevation acute coronary syndromes treated with EPC-capture stents (JACK-EPC trial).
    Wojakowski W; Pyrlik A; Król M; Buszman P; Ochała A; Milewski K; Smolka G; Kawecki D; Rudnik A; Pawłowski T; Jadczyk T; Wyderka R; Cybulski W; Dworowy S; Tendera M
    Minerva Cardioangiol; 2013 Jun; 61(3):301-11. PubMed ID: 23681133
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion.
    Migliorini A; Moschi G; Vergara R; Parodi G; Carrabba N; Antoniucci D
    Catheter Cardiovasc Interv; 2006 Mar; 67(3):344-8. PubMed ID: 16489559
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).
    Ribichini F; Romano M; Rosiello R; La Vecchia L; Cabianca E; Caramanno G; Milazzo D; Loschiavo P; Rigattieri S; Musarò S; Pironi B; Fiscella A; Amico F; Indolfi C; Spaccarotella C; Bartorelli A; Trabattoni D; Della Rovere F; Rolandi A; Beqaraj F; Belli R; Sangiorgio P; Villani R; Berni A; Sheiban I; Lopera Quijada MJ; Cappi B; Ribaldi L; Vassanelli C;
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1012-22. PubMed ID: 24055444
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Outcomes after primary coronary intervention with drug-eluting stent implantation in diabetic patients with acute ST elevation myocardial infarction.
    Zhang Q; Shen J; Zhang RY; Qiu JP; Lu JD; Zhang Y; Chen YH; Zhang JF; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Chin Med J (Engl); 2007 Nov; 120(21):1862-7. PubMed ID: 18067756
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [The impact of comprehensive cardiac rehabilitation in patients up to 55 years old after acute myocardial infarction treated with primary coronary intervention].
    Piestrzeniewicz K; Navarro-Kuczborska N; Bolińska H; Jegier A; Maciejewski M
    Pol Arch Med Wewn; 2004 Mar; 111(3):309-17. PubMed ID: 15230212
    [TBL] [Abstract][Full Text] [Related]  

  • 79. High intensity interval training reduces systemic inflammation in post-PCI patients.
    Munk PS; Breland UM; Aukrust P; Ueland T; Kvaløy JT; Larsen AI
    Eur J Cardiovasc Prev Rehabil; 2011 Dec; 18(6):850-7. PubMed ID: 21450602
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Predictors of improvements in exercise capacity during cardiac rehabilitation in the recovery phase after coronary artery bypass graft surgery versus acute myocardial infarction.
    Suzuki Y; Ito K; Yamamoto K; Fukui N; Yanagi H; Kitagaki K; Konishi H; Arakawa T; Nakanishi M; Goto Y
    Heart Vessels; 2018 Apr; 33(4):358-366. PubMed ID: 29119294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.